Rep. Jonathan L. Jackson Purchases Shares of Tenet Healthcare Corporation (NYSE:THC)

Representative Jonathan L. Jackson (D-Illinois) recently bought shares of Tenet Healthcare Corporation (NYSE:THC). In a filing disclosed on January 08th, the Representative disclosed that they had bought between $15,001 and $50,000 in Tenet Healthcare stock on December 10th. The trade occurred in the Representative’s “MORGAN STANLEY TRUST ACCOUNT” account.

Representative Jonathan L. Jackson also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of Robinhood Markets (NASDAQ:HOOD) on 12/22/2025.
• Purchased $15,001 – $50,000 in shares of Palantir Technologies (NASDAQ:PLTR) on 12/22/2025.
• Sold $15,001 – $50,000 in shares of MercadoLibre (NASDAQ:MELI) on 12/10/2025.
• Sold $50,001 – $100,000 in shares of Netflix (NASDAQ:NFLX) on 12/8/2025.
• Purchased $50,001 – $100,000 in shares of Shopify (NASDAQ:SHOP) on 12/8/2025.
• Sold $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 11/11/2025.
• Purchased $1,001 – $15,000 in shares of State Street (NYSE:STT) on 11/11/2025.
• Sold $1,001 – $15,000 in shares of T-Mobile US (NASDAQ:TMUS) on 11/11/2025.
• Sold $15,001 – $50,000 in shares of Doximity (NASDAQ:DOCS) on 11/6/2025.
• Purchased $15,001 – $50,000 in shares of Robinhood Markets (NASDAQ:HOOD) on 11/6/2025.

Tenet Healthcare Trading Down 0.9%

Shares of Tenet Healthcare stock opened at $201.46 on Friday. The company has a quick ratio of 1.64, a current ratio of 1.71 and a debt-to-equity ratio of 2.27. The firm has a market cap of $17.71 billion, a price-to-earnings ratio of 13.81, a price-to-earnings-growth ratio of 0.86 and a beta of 1.41. Tenet Healthcare Corporation has a 52-week low of $109.82 and a 52-week high of $222.82. The company’s 50-day simple moving average is $202.22 and its 200-day simple moving average is $189.81.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Tuesday, October 28th. The company reported $3.70 earnings per share for the quarter, beating analysts’ consensus estimates of $3.33 by $0.37. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.The company had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same quarter in the previous year, the company earned $2.93 EPS. The firm’s revenue for the quarter was up 3.2% compared to the same quarter last year. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. As a group, equities research analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Nadja West sold 2,178 shares of the company’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the sale, the director directly owned 28,480 shares of the company’s stock, valued at $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Richard W. Fisher sold 2,500 shares of the firm’s stock in a transaction on Wednesday, October 29th. The stock was sold at an average price of $208.43, for a total transaction of $521,075.00. Following the transaction, the director directly owned 8,792 shares of the company’s stock, valued at approximately $1,832,516.56. This represents a 22.14% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 45,500 shares of company stock worth $9,247,071 in the last quarter. Company insiders own 0.81% of the company’s stock.

Hedge Funds Weigh In On Tenet Healthcare

Several hedge funds have recently bought and sold shares of the stock. Diversified Trust Co. increased its holdings in shares of Tenet Healthcare by 99.9% during the 4th quarter. Diversified Trust Co. now owns 4,287 shares of the company’s stock worth $852,000 after buying an additional 2,142 shares during the last quarter. Fulton Bank N.A. increased its stake in Tenet Healthcare by 69.6% during the fourth quarter. Fulton Bank N.A. now owns 1,805 shares of the company’s stock worth $359,000 after acquiring an additional 741 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Tenet Healthcare by 13.4% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 30,661 shares of the company’s stock valued at $6,390,000 after purchasing an additional 3,629 shares in the last quarter. NorthCrest Asset Manangement LLC grew its holdings in shares of Tenet Healthcare by 23.1% during the 4th quarter. NorthCrest Asset Manangement LLC now owns 3,983 shares of the company’s stock worth $825,000 after purchasing an additional 748 shares during the period. Finally, Wedmont Private Capital lifted its position in Tenet Healthcare by 2.5% during the 4th quarter. Wedmont Private Capital now owns 2,088 shares of the company’s stock worth $422,000 after acquiring an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Guggenheim boosted their target price on shares of Tenet Healthcare from $238.00 to $257.00 and gave the stock a “buy” rating in a research report on Tuesday, December 2nd. Zacks Research downgraded shares of Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. Mizuho lifted their price target on shares of Tenet Healthcare from $194.00 to $225.00 and gave the company an “outperform” rating in a research report on Friday, October 17th. TD Cowen lowered their price target on Tenet Healthcare from $233.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $233.81.

About Representative Jackson

Jonathan Jackson (Democratic Party) is a member of the U.S. House, representing Illinois’ 1st Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Jackson (Democratic Party) is running for re-election to the U.S. House to represent Illinois’ 1st Congressional District. He declared candidacy for the 2026 election.

Jonathan Jackson was born in Chicago, Illinois. Jackson graduated from Whitney Young High School. He earned an M.B.A. from Northwestern University. Jackson’s career experience includes working as an investment analyst and an entrepreneur.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.